• 3990 Citations
  • 32 h-Index
1985 …2018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Donatella Aldinucci is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Hodgkin Disease Medicine & Life Sciences
Reed-Sternberg Cells Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Cisplatin Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Cells Chemical Compounds
CD30 Ligand Medicine & Life Sciences
Cell Line Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1985 2018

  • 3990 Citations
  • 32 h-Index
  • 83 Article
  • 1 Review article

CCR5 antagonism by maraviroc inhibits Hodgkin lymphoma microenvironment interactions and xenograft growth

Casagrande, N., Borghese, C., Visser, L., Mongiat, M., Colombatti, A. & Aldinucci, D., Oct 11 2018, In : Haematologica.

Research output: Contribution to journalArticle

Hodgkin Disease
4 Citations (Scopus)

Improved GMP compliant approach to manipulate lipoaspirates, to cryopreserve stromal vascular fraction, and to expand adipose stem cells in xeno-free media

Agostini, F., Rossi, F. M., Aldinucci, D., Battiston, M., Lombardi, E., Zanolin, S., Massarut, S., Parodi, P. C., Da Ponte, A., Tessitori, G., Pivetta, B., Durante, C. & Mazzucato, M., May 11 2018, In : Stem Cell Research and Therapy. 9, 1, 130.

Research output: Contribution to journalArticle

Stem cells
Stromal Cells
Blood Vessels
Stem Cells
Intercellular Signaling Peptides and Proteins
11 Citations (Scopus)

Inhibition of the CCL5/CCR5 axis against the progression of gastric cancer

Aldinucci, D. & Casagrande, N., May 16 2018, In : International Journal of Molecular Sciences. 19, 5, 1477.

Research output: Contribution to journalReview article

C Chemokines
CC Chemokines
Chemokine Receptors
Stomach Neoplasms
28 Citations (Scopus)

New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status

Altaf, M., Monim-ul-Mehboob, M., Kawde, A. N., Corona, G., Larcher, R., Ogasawara, M., Casagrande, N., Celegato, M., Borghese, C., Siddik, Z. H., Aldinucci, D. & Isab, A. A., Jan 1 2017, In : Oncotarget. 8, 1, p. 490-505 16 p.

Research output: Contribution to journalArticle

Cell Line
Gold Compounds
6 Citations (Scopus)

Radiotherapy prolongs the survival of advanced non-smallcell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev)

Pastina, P., Nardone, V., Botta, C., Croci, S., Tini, P., Battaglia, G., Ricci, V., Cusi, M. G., Gandolfo, C., Misso, G., Zappavigna, S., Caraglia, M., Giordano, A., Aldinucci, D., Tassone, P., Tagliaferri, P., Pirtoli, L. & Correale, P., Jan 1 2017, In : Oncotarget. 8, 44, p. 75904-75913 10 p.

Research output: Contribution to journalArticle

Lung Neoplasms